 |
 |
 |

 
To gather more data to help women make a well-informed decision regarding
hormone therapy, researchers at the National Institutes of Health (NIH)
launched the Postmenopausal Estrogen/Progestin Interventions Trial (PEPI)
in 1989. With 127 women enrolled at each of seven medical centers, PEPI
will address the short-term safety and efficacy of various methods of HRT.
The study will compare women who take estrogen by itself to those who take
it with different types of progestin. It will also examine the effects of
both cyclical and continuous progestin on cardiovascular risk factors, blood
clotting factors, metabolism, uterine changes, bone mass, and general quality
of life.
Several new studies are looking
at normal body changes as women move from pre- to postmenopause. Up to
now, the lack of such data has been one problem in assessing the value
of HRT. Without knowing what "normal" is, scientists have difficulty
judging the effect of a particular treatment. Another problem with past
studies is the "healthy user effect." In many trials preceding
PEPI, the HRT users studied had freely chosen to begin treatment, with
advice from their doctors. In general, most physicians discourage women
with a preexisting illness or long family history of breast cancer from
taking HRT. This factor could skew study results to appear that nonusers
became ill or died more frequently simply because they failed to take
estrogen. Only by randomly assigning study participants to the treatment
can this bias be overcome. Until more random trials are completed, the
jury is still out on HRT.
Another NIH study is the Women's
Health Initiative, a multicenter trial involving 70,000 postmenopausal
women ages 50 to 79. The study will assess the long-term benefits and
risk of hormone therapy as it relates to cardiovascular disease, osteoporosis,
and breast and uterine cancer. It will also help determine the effects
of calcium supplementation, dietary changes, and exercise on women in
this age group. Some of the specific questions to be addressed by the
Women's Health Initiative include:
- * How long is estrogen effective
for each system of the body (skeletal, cardiovascular, nervous, endocrine)?
- * What is the best dose and route
of administration of estrogen and progestin to prevent side effects
yet maintain efficacy?
- * How long is estrogen safe to
take?
- * Does estrogen act the same
way in older women as in younger women?
- * Are there effective alternatives
to HRT?
Clearly, no one has all the answers
about menopause. Medical research is beginning to give us more accurate
information, but some myths and negative attitudes persist. Women are
challenging old stereotypes, learning about what's happening in their
bodies, and taking responsibility for their health. The important thing
to remember as you go through menopause is to be good to yourself. Take
time to pursue your hobbies, be they gardening, painting or socializing
with friends. Have a positive attitude toward life. Sharing concerns with
friends, a spouse, relatives or a support group can help. Don't fight
your body--allow the changes that are happening to become a part of you,
a part that is natural and that you accept.
| Many
women feel that their physicians do not listen to their concerns.
Nor do they give them enough information to make an educated decision
about hormone therapy. |
|
 |